The Neurological Monitoring Devices Market in Latin America was worth USD 0.83 billion in 2022 and estimated to be growing at a CAGR of 7.9%, to reach USD 1.22 billion by 2027.
Neuro physiological market vendors will have to utilize resources wisely and focus on product R&D to create flexible and extensively tested user-friendly devices. Manufacturers would also do well to encourage competition, innovation, and dynamism, which are essential for the market's success.
The advances in the field of neurological research and medicine, availability of sophisticated equipment that monitors and tracks nerve and brain activity to make a better diagnosis and offers better treatments to patients, higher incidence of neurological disorders like epilepsy, Parkinson’s, Alzheimer’s, and other neurodegenerative disorders, treatments available for many disorders like nerve repair and regeneration and rise in the aging population are driving the market.
A large population still cannot afford modern healthcare facilities, and a major restrain for the market.
This report has been segmented and sub-segmented the Latin American Neurological Monitoring Devices Market into the following categories:
By Therapeutic Application:
Regionally, Mexico dominated the neurological monitoring devices market for this region and is expected to continue its dominance over the forecast period.
Promising companies dominating the Latin America Neurological Monitoring Devices Market are CAS Medical Systems Inc., Compumedics Ltd., Natus Medical Inc., Philips Healthcare, GE Healthcare, AMD Global Telemedicine, Intel Corporation, Johnson & Johnson, InTouch Health, InTechnology, MEG International Services Ltd., Rimed Inc., Siemens Healthcare, Medtronic Inc., Electrical Geodesics Incorporated, Nihon Kohden Corporation, and Advanced Brain Monitoring.
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: email@example.com